News for 'FDA'

What lies ahead for Sun Pharma post Ranbaxy merger approval

What lies ahead for Sun Pharma post Ranbaxy merger approval

Rediff.com31 Mar 2015

Sun Pharmaceutical's acquisition of Ranbaxy has received final approvals.

Parle knocks on Bombay HC doors over Mango Bite

Parle knocks on Bombay HC doors over Mango Bite

Rediff.com17 Oct 2012

On Oct 14, the Maharashtra unit of FDA had ordered recall of entire stock of Kachha Mango Bite from the marketplace.

Nestle to face more action over Maggi?

Nestle to face more action over Maggi?

Rediff.com21 May 2015

Fast Moving Consumer Goods major Nestle may face more action by the Uttar Pradesh Food Safety and Drug Administration, which is testing more batches of Maggi after ordering recall of a batch of about 2 lakh packs of the instant noodles due to higher than permitted levels of lead and a food additive.

USFDA raises concerns about Ranbaxy's Toansa plant

USFDA raises concerns about Ranbaxy's Toansa plant

Rediff.com13 Jan 2014

All of Ranbaxy's India-based factories are currently banned by the FDA from exporting medicines to the United States, the company's largest market, after the regulator's inspection found violation of its so-called good manufacturing practices.

Indian regulator also scans Ranbaxy

Indian regulator also scans Ranbaxy

Rediff.com20 Sep 2013

The move comes in the wake of many facilities of Ranbaxy in India being barred by the US Food and Drugs Administration for supplying medicines to the US.

Study Abroad: Uncertainty over Vaccination

Study Abroad: Uncertainty over Vaccination

Rediff.com14 Jun 2021

With the US education system operating independently from the government, universities are adopting varying strategies when it comes to Covid vaccination.

Fake drugs land Maharashtra company in dock

Fake drugs land Maharashtra company in dock

Rediff.com3 Oct 2013

Food and Drug Authority Ghana said in a statement that officials of Bliss GVS Pharma of India and Ghanaian drug maker Tobinco Pharmaceuticals have apologised to it for importing 'fake malaria medicine' to Ghana to treat malaria in children.

Covid vaccine boosters not appropriate at this stage: Lancet study

Covid vaccine boosters not appropriate at this stage: Lancet study

Rediff.com13 Sep 2021

The results reported from the observational studies, on average, show that vaccination had 95 per cent efficacy against severe disease both from the Delta variant and from the Alpha variant, and over 80 per cent efficacy at protecting against any infection from these variants.

US drug regulator finds Indian companies critically ill

US drug regulator finds Indian companies critically ill

Rediff.com24 Sep 2013

The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.

Travel firms expect heavy rush as US lifts curbs

Travel firms expect heavy rush as US lifts curbs

Rediff.com18 Oct 2021

Travel companies are expecting a heavy rush to the US following the withdrawal of curbs on fully vaccinated travellers from select countries, including India, on November 8. The move will benefit those holding long-term tourist, business, and work visas. Also, new and extra flights by Air India and American Airlines are expected to provide better travel options.

Available now: A 'female Viagra', but it comes with a warning

Available now: A 'female Viagra', but it comes with a warning

Rediff.com19 Aug 2015

The first drug to treat low sexual desire in premenopausal women, dubbed "female Viagra", has been approved in the United States, but with a warning about potentially dangerous side effects such as severe low blood pressure and fainting.

Hydroxychloroquine doesn't help treat COVID-19: Report

Hydroxychloroquine doesn't help treat COVID-19: Report

Rediff.com22 Apr 2020

Trump has been aggressively promoting the use of hydroxychloroquine in the treatment of COVID-19 patients.

After Ranbaxy, US FDA turns the heat on Actavis

After Ranbaxy, US FDA turns the heat on Actavis

Rediff.com13 Oct 2008

The US Congressional committee, which is inquiring into the country's Food and Drug Administration's handling of drug-marketing approvals of India's leading drug-maker Ranbaxy, has extended its probe into similar permissions given to Iceland's Actavis.

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

Ranbaxy recalls some batches of generic Lipitor in latest quality blow

Rediff.com10 Mar 2014

The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

Why Sun Pharma stock will remain under pressure

Why Sun Pharma stock will remain under pressure

Rediff.com24 Dec 2019

The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality drug payoffs.

Can You SAVE This Mother's Life?

Can You SAVE This Mother's Life?

Rediff.com2 Aug 2022

'As a donor, you may think you are saving one life. But you touch the lives of the entire family and community associated with the person. And it only cost you a few hours of your life.'

COVID-19 vaccine unlikely before Fall of 2021: Experts

COVID-19 vaccine unlikely before Fall of 2021: Experts

Rediff.com2 Oct 2020

Researchers at McGill University in Canada carried out a survey of 28 experts working in vaccinology in late June 2020. The majority of those surveyed were mostly Canadian or American academics with an average of 25 years of experience working in the field.

Why investors are regretting giving Gland Pharma IPO a miss

Why investors are regretting giving Gland Pharma IPO a miss

Rediff.com24 Nov 2020

Gland Pharma, promoted by China's Fosun, has extended its gains, is up 40 per cent since its listing.

Ranbaxy gets US FDA nod for Cefadroxil dosage

Ranbaxy gets US FDA nod for Cefadroxil dosage

Rediff.com27 Mar 2003

Indian drugmaker Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration to market an oral suspension form of Warner Chilcott's Duricef antibiotic, the Bombay Stock Exchange

Reddy's files with US FDA for generic Olanzapine

Reddy's files with US FDA for generic Olanzapine

Rediff.com11 Mar 2003

Drugmaker Dr Reddy's Laboratories has filed an application with the US Food and Drug Administration to market a generic form of Eli Lilly's schizophrenia drug Olanzapine in the US

JB Chem files 1st ANDA, US FDA

JB Chem files 1st ANDA, US FDA

Rediff.com16 Jan 2003

JB Chemicals & Pharmaceuticals Ltd on Thursday announced the filing of its first Abbreviated New Drug Application with the United States Food and Drug Administration.

US FDA tightens screws on sale of diet supplements

US FDA tightens screws on sale of diet supplements

Rediff.com29 Jun 2007

The US Food and Drug Administration has tightened rules for selling dietary supplements in the US market, making compliance with current good manufacturing practices mandatory for manufacturers.

Wockhardt gets FDA nod to market painkillers in US

Wockhardt gets FDA nod to market painkillers in US

Rediff.com20 Mar 2007

Wockhardt Ltd said on Tuesday it has got US Food and Drug Administration's approval to market painkiller tablets containing a combination of Dextropropoxyphene napsylate and Acetaminophen in the US market.

Why Dr Reddy's expects FY19 to be stronger and richer

Why Dr Reddy's expects FY19 to be stronger and richer

Rediff.com6 Mar 2018

The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015

'We put pressure on Biden admn over vaccines'

'We put pressure on Biden admn over vaccines'

Rediff.com13 May 2021

'Supplies should start moving to the Serum Institute without any impediments.'

Local drug makers worried as regulators start working together

Local drug makers worried as regulators start working together

Rediff.com26 Dec 2013

Various domestic companies such as Ranbaxy, Wockhardt and Agila Specialities recently came under the US FDA scanner for lapse in manufacturing practices.

Cipla gets nod to import Moderna vaccine for emergency use in India

Cipla gets nod to import Moderna vaccine for emergency use in India

Rediff.com29 Jun 2021

India's drug regulator Drugs Controller General of India has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, official sources said on Tuesday.

It's a tough road ahead for pharma companies

It's a tough road ahead for pharma companies

Rediff.com29 May 2013

Post Ranbaxy episode, domestic pharma companies may face frequent inspections and deeper scrutiny.

US drug regulator warns RPG Life Sciences

US drug regulator warns RPG Life Sciences

Rediff.com19 Jun 2013

The US Food and Drug Administration (USFDA) has issued a warning letter to RPG Life Sciences for violation of current good manufacturing practice (CGMP) norms at its two plants at Ankleshwar and Mumbai.

India acts to repair reputation as drugs exporter

India acts to repair reputation as drugs exporter

Rediff.com7 May 2014

As part of the charm offensive, New Delhi has invited global regulators -- including the FDA -- to visit Indian production units to get first-hand evidence of measures taken to ensure the quality of locally manufactured generics.

Lupin recalls 9,210 bottles of anti-infective drug from the US

Lupin recalls 9,210 bottles of anti-infective drug from the US

Rediff.com15 Apr 2014

The recent recalls come amid increased FDA scrutiny of medicines produced in India.

Boxing great Mike Tyson advocates for psychedelics

Boxing great Mike Tyson advocates for psychedelics

Rediff.com29 May 2021

Tyson said he wants to spread word of the benefits of psilocybin as widely as possible, which is why he has partnered with Wesana.

J&J licence to make cosmetics at Mulund plant cancelled

J&J licence to make cosmetics at Mulund plant cancelled

Rediff.com25 Jun 2013

The company has been held responsible for the violation of the Drugs and Cosmetic Act, 1940 and the rules framed in 1945.

Hydroxychloroquine can be fatal: Experts

Hydroxychloroquine can be fatal: Experts

Rediff.com6 May 2020

As the pandemic spreads and the urgency for effective treatment of COVID-19 mounts, several countries, including the US, have started relying heavily on HCQ, majorly used in the treatment of malaria and rheumatoid-arthritis.

BJP leaders want re-election in Maharashtra

BJP leaders want re-election in Maharashtra

Rediff.com4 Nov 2019

'Many of them are angry as we could not contest in some seats due to pact with the Sena and lost with a thin margin in some segments'

Zika epidemic: Donated blood across US to be screened for virus

Zika epidemic: Donated blood across US to be screened for virus

Rediff.com28 Aug 2016

The Food and Drug Administration says all those areas are currently in compliance with blood screening, but that expanded testing is now needed.

US gives clean chit to Maggi: Do you want it back?

US gives clean chit to Maggi: Do you want it back?

Rediff.com12 Aug 2015

Nestl India is preparing a blueprint for a possible relaunch.

Your toothpaste can fight lung disease

Your toothpaste can fight lung disease

Rediff.com21 May 2018

A common antibacterial substance found in toothpaste may combat life-threatening diseases such as cystic fibrosis, or CF, when combined with an already FDA-approved drug.

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Rediff.com27 Feb 2014

Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.